Upgrades/Downgrades
Updated: 01-Oct-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| United Therapeutics | UTHR | BTIG Research | Neutral » Buy | $728 | |
| TC Energy | TRP | Goldman | Neutral » Buy | $71 | |
| Regeneron Pharma | REGN | Argus | Hold » Buy | $850 | |
| Occidental Petro | OXY | Goldman | Neutral » Buy | $69 | |
| Hub Group | HUBG | Stifel | Sell » Hold | $29 | |
| Forbright | FRBT | JP Morgan | Neutral » Overweight | $22 | |
| First Hawaiian | FHB | JP Morgan | Underweight » Neutral | $29 | |
| Dollar Tree | DLTR | Loop Capital | Hold » Buy | $140 | |
| Con Edison | ED | Wells Fargo | Equal Weight » Overweight | $118 | |
| BP | BP | Wells Fargo | Equal Weight » Overweight | $57 | |
| BJ Restaurants | BJRI | Mizuho | Neutral » Outperform | $76 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Liquidia Technologies | LQDA | Raymond James | Strong Buy » Outperform | $53 | |
| Sigma Lithium | SGML | BMO Capital Markets | Outperform » Market Perform | $10 | |
| Ormat Tech | ORA | UBS | Buy » Neutral | $100 | |
| Liquidia Technologies | LQDA | BTIG Research | Buy » Neutral | ||
| Exxon Mobil | XOM | Wells Fargo | Overweight » Equal Weight | $182 | |
| Ethos Technologies | LIFE | JP Morgan | Overweight » Neutral | $37 | |
| The Baldwin Group | BWIN | JP Morgan | Overweight » Neutral | $32 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Wave Life Sciences | WVE | Ladenburg Thalmann | Buy | $10 | |
| Rocket Lab USA | RKLB | Citigroup | Buy | $105 | |
| Williams Cos | WMB | Barclays | Overweight | $82 | |
| Whitehawk Therapeutics | WHWK | Stifel | Buy | $9 | |
| Toll Brothers | TOL | Morgan Stanley | Overweight | $159 | |
| The Vita Coco Company | COCO | Oppenheimer | Outperform | $70 | |
| Teva Pharma | TEVA | TD Cowen | Buy | $55 | |
| Spyre Therapeutics | SYRE | JP Morgan | Overweight | $110 | |
| PulteGroup | PHM | Morgan Stanley | Equal-Weight | $128 | |
| NVR | NVR | Morgan Stanley | Underweight | $5058 | |
| National Energy Services Reunited | NESR | BMO Capital Markets | Outperform | $39 | |
| Monte Rosa Therapeutics | GLUE | H.C. Wainwright | Buy | $25 | |
| Lennar | LEN | Morgan Stanley | Underweight | $65 | |
| Kura Oncology | KURA | JP Morgan | Overweight | $30 | |
| KB Home | KBH | Morgan Stanley | Underweight | $39 | |
| Immunome | IMNM | Stifel | Hold | $24 | |
| Freshpet | FRPT | Needham | Hold | ||
| Enliven Therapeutics | ELVN | JP Morgan | Overweight | $75 | |
| Digital Turbine | APPS | RBC Capital Mkts | Outperform | $15 | |
| D.R. Horton | DHI | Morgan Stanley | Equal-Weight | $151 | |
| Civeo | CVEO | Roth Capital | Buy | $39 | |
| Civeo | CVEO | Northland Capital | Outperform | $42 | |
| Amrize | AMRZ | Barclays | Equal Weight | $55 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| First Business Financial | FBIZ | Raymond James | Outperform | $75 | |
| QCR Holdings | QCRH | Raymond James | Outperform | $110 | |
| S&T Bancorp | STBA | Raymond James | Mkt Perform | ||
| Enbridge | ENB | Goldman | Neutral | $50 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Apple | AAPL | Morgan Stanley | Overweight | $360 » $355 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |